Top Consumer Driven Health Care Stories
FDA panel backs expanded use of Merck's Vytorin
By Associated PressFederal health experts are recommending that use of Merck's blockbuster cholesterol drug Vytorin be expanded to patients with kidney disease, but not those with late-stage disease who are on dialysis.
